Source: Virtual Congress 2020 – Screening and early lung cancer
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanchez-Carpintero Abad (Madrid, Spain), J. Zulueta (Pamplona, Spain), J. De Torres (Pamplona, Spain), A. Alcaide (Pamplona, Spain), P. Sanchez Salcedo (Pamplona, Spain), U. Montes (Pamplona, Spain), G. Bastarrika (Pamplona, Spain), A. Campo (Pamplona, Spain). Bronchiectasis and false positive cases in a lung cancer screening program. 1609

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and burden of bronchiectasis in a lung cancer screening program Source: International Congress 2019 – Airway infection in COPD Year: 2019 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Screening for lung cancer Source: Eur Respir Mon; 2009: 44: 57–70 Year: 2009 Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team Source: Eur Respir J 2009; 33: 941-942 Year: 2009 Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 Prevalence of bronchiectasis in a lung cancer screnning program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer Source: Eur Respir J 2006; 28: 1186-1189 Year: 2006 Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The evidence on CT: lung cancer screening Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018 The efficacy of COPD detection by using a community-based annual screening program for lung cancer Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Risk factors and prognosis of non-solid nodules in a lung cancer screening program Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010 Diagnosis problem in smear negative pulmonary tuberculosis: study about 34 cases Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 The current value of mediastinoscopy in the diagnosis of non-lung cancer pathologies Source: Annual Congress 2010 - Oncological problems, surgical risk and complications Year: 2010 Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009